Telemedicine vs in-person delivery of cognitive behavioral treatment of insomnia: a mixed methods analysis
Cognitive behavioral therapy for insomnia (CBT-I) has been the ‘gold standard’ for the treatment of insomnia. Previous research has indicated that metabolism changes when insomnia is treated. The goal of this study is to learn a little bit more and better understand the relationship between insomnia and metabolism.
Your participation will last approximately 2-4 months depending on the group you are randomized in to. The first visit is a screening visit where you will be asked to answer questions about your sleep, thoughts, and feelings as well as a provide a fasting blood draw. If eligible, you will be provided two devices. One is a portable sleep monitoring device that you will wear for one night and a wrist worn device for one week. After study staff receive the devices back you will be randomized in to one of 2 groups: CBT-I right away or a waitlist group where you will wait 8 weeks prior to starting CBT-I.
CBT-I is currently being offered either in-person or via telemedicine, at the patients' preference.
Following treatment, you will be given the wrist worn device to wear for a week and will come in to the office for another fasting blood draw and to answer questionnaires about 2 weeks after treatment. Three months after the end of treatment, you will be asked to complete a series of questionnaires online.
If you are randomized to the waitlist control group, you will wait 8 weeks prior to starting treatment. After the 8 weeks, you will come in about an hour before your first treatment session to repeat a fasting blood draw and questionnaires. After this is completed, you will start treatment and follow the same structure as listed above.
- Study Identifier: 827001